Tag: United States
Bristol entrepreneur who exited for $800M doubles-down on the city with deep-tech incubator and VC fund
Harry Destecroix co-founded Ziylo while studying for his PhD at the University of Bristol. Ziylo, a university spin-out company, developed a synthetic molecule allowing glucose to bind with the bloodstream more effectively. Four years later, and by then a Phd, Destecroix sold the company to Danish firm Novo Nordisk, one…
Read More
Microsoft announces its first Azure data center region in Denmark
Microsoft continues to expand its global Azure data center presence at a rapid clip. After announcing new regions in Austria and Taiwan in October, the company today revealed its plans to launch a new region in Denmark. As with many of Microsoft’s recent announcements, the company is also attaching a…
Read More
Everlywell raises $175 million to expand virtual care options and scale its at-home health testing
Digital health startup Everlywell has raised a $175 million Series D funding round, following relatively fast on the heels of a $25 million Series C round it closed in February of this year. The Series D included a host of new investors, including BlackRock, The Chernin Group (TCG), Foresite Capital,…
Read More
Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from contracting COVID-19 across 196 confirmed cases from among 30,000 participants in the study. Moderna also found that it was 100%…
Read More
The Supreme Court will hear its first big CFAA case
The Supreme Court will hear arguments on Monday in a case that could lead to sweeping changes to America’s controversial computer hacking laws — and affecting how millions use their computers and access online services. The Computer Fraud and Abuse Act was signed into federal law in 1986 and predates…
Read More
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 clinical trial was actually administered by accident. AstraZeneca and its partner the University of Oxford…
Read More